Yield10 Bioscience, Inc. (YTEN)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.9 Million USD | -51.68% |
| 2022 | 8.08 Million USD | -60.4% |
| 2021 | 20.41 Million USD | 40.58% |
| 2020 | 14.52 Million USD | -13.14% |
| 2019 | 16.71 Million USD | 29.0% |
| 2018 | 12.96 Million USD | -23.23% |
| 2017 | 16.88 Million USD | 57.07% |
| 2016 | 10.74 Million USD | -37.1% |
| 2015 | 17.08 Million USD | -26.14% |
| 2014 | 23.13 Million USD | -13.48% |
| 2013 | 26.73 Million USD | -50.03% |
| 2012 | 53.51 Million USD | -35.46% |
| 2011 | 82.91 Million USD | 24.17% |
| 2010 | 66.77 Million USD | -31.55% |
| 2009 | 97.55 Million USD | 0.63% |
| 2008 | 96.94 Million USD | -18.54% |
| 2007 | 119 Million USD | -6.73% |
| 2006 | 127.59 Million USD | 1642.02% |
| 2005 | 7.32 Million USD | -2.47% |
| 2004 | 7.5 Million USD | 0.0% |
| 2002 | -25.2 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.96 Million USD | -30.05% |
| 2024 Q1 | 4.24 Million USD | 8.6% |
| 2023 Q4 | 3.9 Million USD | -35.34% |
| 2023 Q1 | 5.33 Million USD | -34.03% |
| 2023 FY | 3.9 Million USD | -51.68% |
| 2023 Q3 | 6.04 Million USD | 2.93% |
| 2023 Q2 | 5.87 Million USD | 10.05% |
| 2022 Q4 | 8.08 Million USD | -28.27% |
| 2022 FY | 8.08 Million USD | -60.4% |
| 2022 Q1 | 17.1 Million USD | -16.22% |
| 2022 Q2 | 14.27 Million USD | -16.55% |
| 2022 Q3 | 11.27 Million USD | -21.03% |
| 2021 Q1 | 27.56 Million USD | 89.84% |
| 2021 FY | 20.41 Million USD | 40.58% |
| 2021 Q4 | 20.41 Million USD | -11.03% |
| 2021 Q3 | 22.94 Million USD | -8.98% |
| 2021 Q2 | 25.21 Million USD | -8.55% |
| 2020 Q2 | 13.36 Million USD | -11.17% |
| 2020 Q4 | 14.52 Million USD | -12.76% |
| 2020 Q3 | 16.64 Million USD | 24.54% |
| 2020 FY | 14.52 Million USD | -13.14% |
| 2020 Q1 | 15.04 Million USD | -10.0% |
| 2019 Q4 | 16.71 Million USD | 77.49% |
| 2019 Q3 | 9.41 Million USD | -15.57% |
| 2019 Q2 | 11.15 Million USD | -14.81% |
| 2019 Q1 | 13.09 Million USD | 1.04% |
| 2019 FY | 16.71 Million USD | 29.0% |
| 2018 Q3 | 10.13 Million USD | -15.6% |
| 2018 Q4 | 12.96 Million USD | 27.85% |
| 2018 Q2 | 12.01 Million USD | -14.45% |
| 2018 Q1 | 14.04 Million USD | -16.83% |
| 2018 FY | 12.96 Million USD | -23.23% |
| 2017 Q2 | 6.06 Million USD | -28.56% |
| 2017 FY | 16.88 Million USD | 57.07% |
| 2017 Q4 | 16.88 Million USD | 202.98% |
| 2017 Q3 | 5.57 Million USD | -8.17% |
| 2017 Q1 | 8.49 Million USD | -20.97% |
| 2016 Q2 | 9.38 Million USD | -11.44% |
| 2016 Q3 | 13.52 Million USD | 44.08% |
| 2016 Q4 | 10.74 Million USD | -20.53% |
| 2016 FY | 10.74 Million USD | -37.1% |
| 2016 Q1 | 10.6 Million USD | -37.97% |
| 2015 Q2 | 26.92 Million USD | 61.52% |
| 2015 FY | 17.08 Million USD | -26.14% |
| 2015 Q1 | 16.67 Million USD | -27.94% |
| 2015 Q3 | 22.12 Million USD | -17.85% |
| 2015 Q4 | 17.08 Million USD | -22.75% |
| 2014 Q2 | 11.37 Million USD | -34.73% |
| 2014 FY | 23.13 Million USD | -13.48% |
| 2014 Q1 | 17.42 Million USD | -34.82% |
| 2014 Q3 | 28.79 Million USD | 153.12% |
| 2014 Q4 | 23.13 Million USD | -19.65% |
| 2013 Q3 | 32.5 Million USD | -16.04% |
| 2013 Q4 | 26.73 Million USD | -17.74% |
| 2013 Q2 | 38.71 Million USD | -15.03% |
| 2013 Q1 | 45.56 Million USD | -14.85% |
| 2013 FY | 26.73 Million USD | -50.03% |
| 2012 FY | 53.51 Million USD | -35.46% |
| 2012 Q3 | 60.96 Million USD | -8.91% |
| 2012 Q2 | 66.93 Million USD | -8.46% |
| 2012 Q1 | 73.11 Million USD | -11.81% |
| 2012 Q4 | 53.51 Million USD | -12.23% |
| 2011 Q3 | 91.4 Million USD | -8.13% |
| 2011 FY | 82.91 Million USD | 24.17% |
| 2011 Q4 | 82.91 Million USD | -9.29% |
| 2011 Q2 | 99.49 Million USD | 73.91% |
| 2011 Q1 | 57.21 Million USD | -14.32% |
| 2010 Q2 | 82.21 Million USD | -6.23% |
| 2010 Q4 | 66.77 Million USD | -10.53% |
| 2010 Q1 | 87.67 Million USD | -10.13% |
| 2010 Q3 | 74.62 Million USD | -9.23% |
| 2010 FY | 66.77 Million USD | -31.55% |
| 2009 Q2 | 84.01 Million USD | -5.05% |
| 2009 Q4 | 97.55 Million USD | 28.07% |
| 2009 FY | 97.55 Million USD | 0.63% |
| 2009 Q3 | 76.17 Million USD | -9.34% |
| 2009 Q1 | 88.48 Million USD | -8.73% |
| 2008 FY | 96.94 Million USD | -18.54% |
| 2008 Q1 | 113.42 Million USD | -4.69% |
| 2008 Q4 | 96.94 Million USD | -4.13% |
| 2008 Q2 | 108.35 Million USD | -4.47% |
| 2008 Q3 | 101.12 Million USD | -6.67% |
| 2007 Q4 | 119 Million USD | -2.78% |
| 2007 Q2 | 123.11 Million USD | -0.87% |
| 2007 Q1 | 124.18 Million USD | -2.67% |
| 2007 FY | 119 Million USD | -6.73% |
| 2007 Q3 | 122.41 Million USD | -0.57% |
| 2006 FY | 127.59 Million USD | 1642.02% |
| 2006 Q2 | 22.04 Million USD | -1.27% |
| 2006 Q3 | 21.38 Million USD | -2.99% |
| 2006 Q4 | 127.59 Million USD | 496.69% |
| 2006 Q1 | 22.32 Million USD | 204.84% |
| 2005 FY | 7.32 Million USD | -2.47% |
| 2005 Q4 | 7.32 Million USD | 0.0% |
| 2004 Q4 | 7.5 Million USD | 0.0% |
| 2004 FY | 7.5 Million USD | 0.0% |
| 2002 FY | -25.2 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 850.62 Million USD | 99.541% |
| Muliang Viagoo Technology, Inc. | 25.09 Million USD | 84.429% |
| N2OFF, Inc. | 7.24 Million USD | 46.067% |
| Arcadia Biosciences, Inc. | 19.7 Million USD | 80.173% |